The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer.
Melosky B, Cheema P, Juergens RA, Leighl NB, Liu G, Wheatley-Price P, Sacher A, Snow S, Tsao MS, McLeod D, Chu Q.
Melosky B, et al.
Ther Adv Med Oncol. 2021 Nov 15;13:17588359211056306. doi: 10.1177/17588359211056306. eCollection 2021.
Ther Adv Med Oncol. 2021.
PMID: 34804219
Free PMC article.
Review.
BACKGROUND: Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. Overall survival is suboptimal due to the high metastatic potential of early-stage NSCLC and there is substantial clinical need for additional efficac …
BACKGROUND: Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. Overall su …